Oramed Pharmaceuticals ORMP
NASDAQ ORMP
$4.14 -0.01 (-0.24%)
At close: Oct 21, 2026 · 4:00 PM EDT

Oramed Pharmaceuticals (ORMP) Other Non-Current Liabilities (2011 - 2024)

Updated

Oramed Pharmaceuticals (ORMP) recorded Other Non-Current Liabilities of $60,000 in Q4 2024, down 4.8% from $63,000 a year earlier and unchanged from the prior quarter.

Analysis

Oramed Pharmaceuticals (ORMP) Other Non-Current Liabilities (2011 - 2024) Analysis & Trends

Starting with Q4 2011, Oramed Pharmaceuticals' Other Non-Current Liabilities history includes 51 quarters.

  • Annual Other Non-Current Liabilities has a five-year compound annual growth rate of -44.6% (FY2019 to FY2024).
  • Across earlier years, Other Non-Current Liabilities came in at $63,000 in FY2023 (+3.3%), $61,000 in FY2022 (-38.4%), $99,000 in FY2021 and $1.03 million in FY2020 (-9.9%).
  • Quarterly Other Non-Current Liabilities has ranged from $59,000 in Q1 2023 to $1.03 million in Q4 2020 over the past five years.
  • On a year-over-year basis, Other Non-Current Liabilities has declined for three consecutive quarters, with an average decline of 4.5% over the last eight quarters.
  • Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 10.0% in Q2 2023, against a decline of 88.0% in Q4 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $60,000 (Q3 2024), $60,000 (Q2 2024) and $63,000 (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Oramed Pharmaceuticals 169.50 Mn -165.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 60,000.00
Sep 30, 2024 60,000.00
Jun 30, 2024 60,000.00
Mar 31, 2024 63,000.00
Dec 31, 2023 74,000.00
Sep 30, 2023 61,000.00
Jun 30, 2023 66,000.00
Mar 31, 2023 59,000.00
Dec 31, 2022 61,000.00
Sep 30, 2022 61,000.00
Jun 30, 2022 60,000.00
Mar 31, 2022 99,000.00
Nov 30, 2021 122,000.00
Aug 31, 2021 124,000.00
May 31, 2021 171,000.00
Feb 28, 2021 188,000.00
Nov 30, 2020 223,000.00
Aug 31, 2020 1.24 Mn
May 31, 2020 205,000.00
Feb 29, 2020 243,000.00
API Access

Oramed Pharmaceuticals Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ORMP&period=max&api_key=YOUR_API_KEY